• Carboxylesterase Interference in Amplex Red H2O2 Assays: Imp

  2026-07-30

  Miwa et al. (2016) demonstrated that carboxylesterases can convert Amplex Red to resorufin independently of hydrogen peroxide, leading to significant overestimation of mitochondrial H2O2 release in commonly used assays. These findings highlight a critical methodological pitfall in reactive oxygen species measurement and suggest the need for revised protocols in oxidative stress research.

• Fulvestrant (ICI 182,780): Applied Workflows in Breast Cance

  2026-07-30

  Fulvestrant (ICI 182,780) stands out as a gold-standard ER antagonist, driving both apoptosis and enhanced chemotherapy sensitivity in advanced breast cancer models. This article delivers actionable protocols, troubleshooting tactics, and translational strategies to maximize research impact with APExBIO’s Fulvestrant.

• CTOP in Mechanistic Opioid Research: Beyond Receptor Antagon

  2026-07-29

  Explore how CTOP, a selective μ-opioid receptor antagonist, advances mechanistic opioid signaling research with unprecedented clarity. This article uniquely connects circuit-level discoveries to practical assay choices for pain and neuropharmacology studies.

• Peroxidasin Enhances Glycolysis and Malignancy in Glioblasto

  2026-07-29

  This study identifies peroxidasin (PXDN) as a critical modulator of glycolytic metabolism in glioblastoma, acting through the regulation of LDHA to promote tumor progression. The findings highlight PXDN as a promising diagnostic biomarker and potential therapeutic target for glioblastoma, with implications for energy metabolism assay development.

• ARCA Cy3 EGFP mRNA (5-moUTP): Mechanisms, Innovations, and A

  2026-07-28

  Explore the advanced mechanisms and assay advantages of ARCA Cy3 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified mRNA, for high-fidelity fluorescent mRNA delivery and localization studies. This article dissects the science behind its unique features and practical implications for translational research.

• Protease Inhibitor Cocktail: Enhancing Protein Stability in

  2026-07-28

  The Protease Inhibitor Cocktail (100X H₂O, EDTA Plus) from APExBIO empowers high-fidelity lipid droplet metabolism studies by preserving labile protein complexes during extraction. Discover tested workflows, troubleshooting strategies, and unique advantages that differentiate this protease inhibitor mixture for advanced DFCP1-ATGL axis research.

• Clodronate Liposomes: Redefining Macrophage Function in Agin

  2026-07-27

  Explore how Clodronate Liposomes empower precise in vivo macrophage depletion, with a special focus on aging models and mitochondrial redox regulation. Uncover unique assay considerations and actionable insights for advanced immune cell studies.

• Steroid-Induced Protoplast Lysis: Mechanism and Research Imp

  2026-07-27

  Smith and Shay’s 1965 study introduced a protoplast-based approach to dissect the membrane-disruptive effects of synthetic steroids, revealing that direct action on microbial membranes, rather than cell wall exclusion, underpins their antimicrobial activity. These insights continue to inform the design of mechanistic assays and the interpretation of polyene antifungal antibiotic effects in fungal infection research.

• Ketamine's Immunomodulation in LPS-Induced Depression: mTOR

  2026-07-26

  This study demonstrates that ketamine alleviates depressive-like behavior in mice through immunomodulatory effects, notably reducing microglial activation and brain monocyte infiltration. Importantly, the work links ketamine’s antidepressant actions to mTOR signaling, with implications for targeted intervention in inflammation-associated depression.

• In Vitro Susceptibility of Canine Staphylococci to Novobioci

  2026-07-25

  This study systematically evaluates the in vitro activity of novobiocin and mupirocin against methicillin-susceptible and methicillin-resistant staphylococci isolated from healthy dogs and dogs with superficial pyoderma. The findings refine antimicrobial selection for veterinary dermatology and inform future antibacterial resistance research.

• Recombinant Mouse Sonic Hedgehog: Experimental Workflows & I

  2026-07-24

  Recombinant Mouse Sonic Hedgehog (SHH) protein enables precise modeling of morphogen-driven development and congenital malformation in vitro. This guide translates new comparative findings into actionable protocols, troubleshooting, and workflow enhancements for hedgehog signaling pathway research.

• Lysoptosis: Conserved Cell Death Via Cathepsin Activity Mode

  2026-07-24

  The reference study identifies lysoptosis as a distinct, evolutionarily conserved lysosome-dependent cell death pathway, regulated by intracellular serpins. This discovery clarifies the mechanistic role of cathepsin release and cysteine protease activity in cellular demise, opening avenues for precise investigation into regulated cell death in both model organisms and mammalian systems.

• GPNMB-Based Model Predicts Immunotherapy Response in ESCC

  2026-07-23

  This study introduces a multimodal predictive model integrating circulating GPNMB, CAF-epithelial niche features, and clinical data to forecast immunotherapy response in esophageal squamous cell carcinoma (ESCC). The research elucidates how tumor-derived soluble GPNMB contributes to CD8+ T cell exhaustion and resistance to PD-1 blockade, informing precision patient stratification strategies.

• Ziprasidone HCl: Protocols and Innovations in Translational

  2026-07-23

  Ziprasidone HCl stands out as a dual-action tool for neuroscience and oncology research, enabling precise control of dopaminergic and serotonergic pathways and targeting tumor metabolism. This article decodes advanced workflows, highlights a breakthrough formulation method for enhanced bioavailability, and delivers actionable troubleshooting insights for bench scientists.

• MLN8237 (Alisertib): Mechanistic Leverage for Translational

  2026-07-22

  This thought-leadership article provides a strategic, evidence-based exploration of MLN8237 (Alisertib) as a selective Aurora A kinase inhibitor, integrating deep mechanistic insight with actionable guidance for translational researchers. Drawing on recent molecular mechanistic assays and advanced workflow experiences, it outlines a modern roadmap for leveraging MLN8237 in cancer biology, apoptosis induction, and tumor suppression, while contextualizing its competitive advantages and real-world translational relevance.

443 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page